Macrophage Migration Inhibitory Factor (MIF) as a Central Regulator of Tumor Progression and Immune Evasion
Cellular Physiology and Biochemistry · 2026
DOI: 10.33594/000000878 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Physiology and Biochemistry, 2026. Verfasst von Aygun Aliyarbayova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cytology, Embryology and Histology, Azerbaijan Medical University, Baku, Azerbaijan. Hauptthemen laut MEDLINE: Macrophage Migration-Inhibitory Factors, Neoplasms, Intramolecular Oxidoreductases. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Macrophage migration inhibitory factor has emerged as a central regulator of tumor progression and immune evasion. Initially identified as an inflammatory cytokine, it is now understood as a multifunctional signaling molecule that integrates hypoxia, metabolic stress, oncogenic activation, and tumor microenvironmental remodeling across diverse malignancies. Through pathways involving cluster of differentiation 74, cluster of differentiation 44, and C-X-C motif chemokine receptor 4, macrophage migration inhibitory factor promotes proliferation, survival, angiogenesis, epithelial-mesenchymal transition, invasion, and metastatic competence. It also shapes the tumor microenvironment by enhancing suppressive myeloid infiltration, macrophage polarization, cluster of differentiation 8-positive T-cell exhaustion, regulatory T-cell accumulation, and impaired antigen presentation. These combined effects position macrophage migration inhibitory factor as an immunometabolic mediator linking chronic inflammation with malignant adaptation and therapeutic resistance. Elevated signaling is associated with poor prognosis and reduced response to chemotherapy, radiotherapy, targeted therapy, and immune checkpoint blockade. Overall, macrophage migration inhibitory factor represents a mechanistically important and translationally relevant target whose clinical value will depend on precise biomarker-guided therapeutic integration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cytology, Embryology and Histology, Azerbaijan Medical University, Baku, Azerbaijan.
- Department of Medical Biology and Genetics, Azerbaijan Medical University, Baku, Azerbaijan.
- Department of Oncology, Azerbaijan Medical University, Baku, Azerbaijan.
- Department of Pathology, Azerbaijan Medical University, Baku, Azerbaijan.
Zitieren
APA
Aliyarbayova, A., Shakaraliyeva, Y., Valiyeva, H., Mehdiyeva, N., Huseynov, E., Guliyeva, K., & Ganbayeva, S. (2026). Macrophage Migration Inhibitory Factor (MIF) as a Central Regulator of Tumor Progression and Immune Evasion. Cellular Physiology and Biochemistry. https://doi.org/10.33594/000000878
Vancouver
Aliyarbayova A, Shakaraliyeva Y, Valiyeva H, Mehdiyeva N, Huseynov E, Guliyeva K, et al. Macrophage Migration Inhibitory Factor (MIF) as a Central Regulator of Tumor Progression and Immune Evasion. Cellular Physiology and Biochemistry. 2026. doi:10.33594/000000878
BibTeX
@article{Aliyarbayova2026,
author = {Aliyarbayova, Aygun and Shakaraliyeva, Yegana and Valiyeva, Hagigat and Mehdiyeva, Nigar and Huseynov, Elchin and Guliyeva, Konul and Ganbayeva, Shabnam},
title = {Macrophage Migration Inhibitory Factor (MIF) as a Central Regulator of Tumor Progression and Immune Evasion},
journal = {Cellular Physiology and Biochemistry},
year = {2026},
doi = {10.33594/000000878}
}
EUVIMED